LUCID DIAGNOSTICS INC.

Analyst Reco. Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Delayed Nasdaq Other stock markets 08:11:08 03/05/2024 pm IST			5-day change	1st Jan Change
0.9519 ^USD	+0.20%		+39.35%	-32.49%

27/03	Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	MT
26/03	Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	27/03	MT
Needham Adjusts Price Target on Lucid Diagnostics to $2.80 From $2.60, Maintains Buy Rating	17/23/17	MT
BTIG Adjusts Lucid Diagnostics' Price Target to $3.50 From $5, Keeps Buy Rating	18/22/18	MT
Needham Adjusts Price Target on Lucid Diagnostics to $3.10 From $4.25, Maintains Buy Rating	15/22/15	MT
Needham Cuts Price Target on Lucid Diagnostics to $4.25 From $5, 2023 Revenue Estimate to $15 Million From $20.8 Million; Buy Rating Kept	16/22/16	MT
Needham Adjusts Lucid Diagnostics' Price Target to $5 From $7 on 'Peer Multiple Compression,' Reiterates Buy Rating	12/22/12	MT
Canaccord Genuity Adjusts Lucid Diagnostics' Price Target to $12 From $18, Reiterates Buy Rating	29/22/29	MT
Needham Adjusts Lucid Diagnostics' Price Target to $7 From $13, Citing Peer Multiple Compression, Lowered Revenue Expectation; Buy Rating Kept	29/22/29	MT
Ascendiant Capital Starts Lucid Diagnostics at Buy With $16 Price Target	27/21/27	MT
Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple Contraction;' Buy Rating Kept	15/21/15	MT
Canaccord Genuity Initiates Lucid Diagnostics at Buy Rating With $18 Price Target	08/21/08	MT
BTIG Starts Lucid Diagnostics at Buy with $14 Price Target	08/21/08	MT
Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target	08/21/08	MT
Needham Starts Lucid Diagnostics at Buy With $17 Price Target	08/21/08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer